CNIO - Spanish National Cancer Research Centre
José Carlos González Álvarez is a dedicated researcher currently serving as a PhD candidate at the CNIO - Spanish National Cancer Research Centre since November 2018, under the guidance of Dr. María A. Previously, José held positions as a Graduate Research Fellow at Instituto de Investigaciones Biomédicas de Madrid - CSIC, with Dr. Olivier Vincent as advisor, and as an Undergraduate Research Fellow at GENyO, where collaboration was with Prof. Pedro Medina Vico. José has also gained international experience as an Erasmus+ Summer Intern at the University of Oxford's Biochemistry Department, advised by Associate Prof. Jason Schnell, and participated in summer research with Prof. Christina Redfield at Oxford University. José's educational background includes a Master of Science in Biological and Biomedical Sciences from Universidad Autónoma de Madrid and a Bachelor of Science in Biochemistry from Universidad de Granada. Additionally, José has experience in performing arts, having worked as an actor and singer with the "La Butaca Vacía" Theatre Group from 2010 to 2014.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.